/GCO

Genesco Inc

GCO

$35.12USD↑+5.43%+1.81 today

MARKET CAP

390.1M

P/E (TTM)

28.1x

FWD P/E

—

DAY RANGE

$34 – $35

52W RANGE

$22

$44

AI Summary

Stalk

Sell NowMedium

GCO is in a Stage 4 decline with a clear lower-high/lower-low sequence. Price sits below its declining 9, 20, and 50 EMAs, confirming supply dominance and a bearish medium-term bias. Timing conditions support selling now, ideally into any relief rally back into the EMA resistance zone. A sustained break and hold above the short-term EMAs with follow-through would invalidate this bearish stance.

↑Journeys brand drove 9% comparable-sales gain for eighth straight quarter
↑21 new 4.0 stores delivered >25% sales lift; 80 additional openings planned
↓Q2 revenue fell 3% YoY to $530 M, with comps down 1% amid headwinds

Full analysis →

Buying

6

institutions

Selling

2

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	909.99 K	30.73 M	+59.76 K	+24.7%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	400.19 K	13.51 M	+66.89 K	+39.9%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	149.50 K	5.05 M	+12.57 K	+27.2%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	38.40 K	1.34 M	+30.22 K	+487.3%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUY	19.10 K	645.01 K	+6.70 K	+79.4%	0.00%
MG Man Group Plc Q2 2026	SELL	12.41 K	418.98 K	+-63.18 K	-80.9%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUYNEW	7.64 K	258.10 K	+7.64 K	+0.0%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-33.46 K	-100.0%	0.00%